Model DetailsBlood vessel hemangiosarcoma(Spleen)
Model Name |
Blood vessel hemangiosarcoma (Spleen) | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
vascular neoplasm • splenic hemangiosarcoma • spleen hemangiosarcoma • hemangiosarcoma |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Spleen | Male |
0.6% (2 of 350 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Spleen | Male |
0.6% (2 of 350 mice) |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Spleen | Male |
0.4% (4 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Spleen | Female |
0.7% (6 of 890 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Spleen | Male |
1.7% (1 of 59 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Spleen | Male |
5.0% (3 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 | |
| Spleen | Male |
3.3% (2 of 60 mice) |
|
Tannehill-Gregg SH, Toxicol Sci 2007 Jul;98(1):258-70 |